Reitmans Limited (TSE:RET – Get Free Report) Senior Officer Richard Wait sold 24,600 shares of Reitmans stock in a transaction on Friday, November 1st. The stock was sold at an average price of C$2.66, for a total transaction of C$65,436.00.
Richard Wait also recently made the following trade(s):
- On Wednesday, October 30th, Richard Wait sold 10,100 shares of Reitmans stock. The stock was sold at an average price of C$2.68, for a total transaction of C$27,068.00.
- On Monday, September 30th, Richard Wait sold 10,000 shares of Reitmans stock. The stock was sold at an average price of C$2.54, for a total value of C$25,400.00.
- On Friday, September 27th, Richard Wait sold 20,000 shares of Reitmans stock. The stock was sold at an average price of C$2.50, for a total value of C$50,000.00.
Reitmans Stock Performance
The company has a 50-day moving average of C$0.27. Reitmans Limited has a 52-week low of C$0.18 and a 52-week high of C$3.15. The firm has a market capitalization of C$13.19 million and a price-to-earnings ratio of -0.09. The company has a current ratio of 1.10, a quick ratio of 0.26 and a debt-to-equity ratio of 188.87.
Reitmans Company Profile
Reitmans (Canada) Limited primarily engages in the retail of women's wearing apparel in Canada. Its products include shirts, blouses, pants, dresses, skirts, sweaters, outerwear, activewear, lingerie, and accessories. The company also offers apparel for men. It serves customers through retail and e-commerce channels, under the Reitmans, Addition Elle, Penningtons, RW & CO., Thyme Maternity, and Hyba brand names.
Featured Stories
- Five stocks we like better than Reitmans
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Intel: Is Now the Time to Be Brave?Â
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Investing In Preferred Stock vs. Common Stock
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Reitmans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reitmans and related companies with MarketBeat.com's FREE daily email newsletter.